Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024
Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea and oral mucositis
In honor of World Rainforest Day (June 22), Jaguar is proud to share RealPharma podcast interview with ethnobotanist Dr. Steven King
Read More
Labor Smart, Inc. (OTC PINK:LTNC) (the “Company”) through its wholly owned subsidiary, Next Gen Beverages, maker of performance drink brand, LOCK'DIN, is pleased to announce it held a town square on X (formerly Twitter) Spaces on June 18th. The following topics were discussed:
Read More